XML 63 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segments and Geographic Information
 6 Months Ended
Mar. 29, 2014
Segment Reporting [Abstract]  
Business Segments and Geographic Information

(11) Business Segments and Geographic Information

The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, contingent consideration charges, acquisition related fair value adjustments and integration expenses, restructuring and divestiture charges and other one-time or unusual items and related tax effects.

 

Identifiable assets for the four principal operating segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its four reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues during the three and six months ended March 29, 2014 and March 30, 2013. Segment information is as follows:

 

     Three Months Ended     Six Months Ended  
     March 29,
2014		      March 30,
2013		     March 29,
2014		      March 30,
2013		  

Total revenues:

           

Diagnostics

    $ 290,802       $ 296,507      $ 576,568       $ 602,423   

Breast Health

      238,705         220,058        465,196         440,866   

GYN Surgical

      72,043         73,692        150,897         154,601   

Skeletal Health

      23,458         22,406        44,795         46,135   
  

 

 

     

 

 

    

 

 

     

 

 

  
   $ 625,008       $ 612,663      $ 1,237,456       $ 1,244,025   
  

 

 

     

 

 

    

 

 

     

 

 

  

Operating income (loss):

           

Diagnostics

    $ 15,243       $ (46,978 )    $ 19,997       $ (32,683 ) 

Breast Health

      25,818         47,892        69,667         92,837   

GYN Surgical

      6,579         2,241        17,702         2,863   

Skeletal Health

      2,610         2,387        4,169         5,754   
  

 

 

     

 

 

    

 

 

     

 

 

  
   $ 50,250       $ 5,542      $ 111,535       $ 68,771   
  

 

 

     

 

 

    

 

 

     

 

 

  

Depreciation and amortization:

           

Diagnostics

    $ 94,612       $ 89,402      $ 186,798       $ 180,944   

Breast Health

      9,163         10,124        18,524         20,054   

GYN Surgical

      26,042         26,524        52,088         53,003   

Skeletal Health

      227         226        453         430   
  

 

 

     

 

 

    

 

 

     

 

 

  
   $ 130,044       $ 126,276      $ 257,863       $ 254,431   
  

 

 

     

 

 

    

 

 

     

 

 

  

Capital expenditures:

           

Diagnostics

    $ 14,841       $ 13,464      $ 25,097       $ 27,318   

Breast Health

      2,275         5,910        4,080         9,490   

GYN Surgical

      2,194         2,171        3,980         4,916   

Skeletal Health

      40         28        182         206   

Corporate

      2,006         2,823        4,402         4,913   
  

 

 

     

 

 

    

 

 

     

 

 

  
   $ 21,356       $ 24,396      $ 37,741       $ 46,843   
  

 

 

     

 

 

    

 

 

     

 

 

  

 

     March 29,
2014		      September 28,
2013		  

Identifiable assets:

      

Diagnostics

    $ 4,528,340       $ 4,667,942   

Breast Health

      877,923         932,206   

GYN Surgical

      1,802,207         1,849,518   

Skeletal Health

      33,369         33,508   

Corporate

      1,120,556         1,517,649   
  

 

 

     

 

 

  
   $ 8,362,395       $ 9,000,823   
  

 

 

     

 

 

  

The Company had no customers with balances greater than 10% of accounts receivable as of March 29, 2014 or September 28, 2013, or any customer that represented greater than 10% of consolidated revenues during the three and six months ended March 29, 2014 and March 30, 2013.

The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, Germany and the United Kingdom. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “All others” designation includes Canada, Latin America and the Middle East.

 

Revenues by geography as a percentage of total revenues were as follows:

 

     Three Months Ended      Six Months Ended  
     March 29,
2014		      March 30,
2013		      March 29,
2014		      March 30,
2013		  

United States

      74%         75%         74%         74%   

Europe

      15%         12%         15%         14%   

Asia-Pacific

      7%         9%         7%         8%   

All others

      4%         4%         4%         4%   
  

 

 

     

 

 

     

 

 

     

 

 

  
     100%         100%         100%         100%